Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. Contact Patent Forecast for full access.        

AI Biotech/Diagnostics: Other Innovation

Read More News and Insights

The First Company to use Genomic Data for Fitness Recommendations. Should other Companies Take Note?

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

February 25, 2021

There is no doubt that improved technologies have greatly reduced the amount of time necessary to sequence human genomes. In the past, it would take weeks or even months to sequence a single person's genome. Modern technology has greatly improved our capabilities, and the entire genome can now be sequenced in just a few hours. No longer is it cost or time prohibitive to sequence human genomic data. Now that the technology is present to obtain genomic data, companies have begun to capitalize. 

The first example of commercialization of genomic data was with companies like 23AndMe and Ancestry.com, who use genomic data to allow consumers to learn more about their ancestral roots. Then, a few months ago, we wrote about DNANudge, a London-based company who uses genomic data to make recommendations and suggestions for purchasing foods that will fit best with a given person's genes. 

Now, a new use for genomic data has emerged: Exercise Plans Catered to your Genomic Data. This past week, FitnessGenes LTD. had their second application published (US. Pat. Pub. No. 20210050086). The application teaches a method of “generating an optimized workout plan for an individual based on the individual's genetic, physiological, behavioral and lifestyle data.” Using a person's genetic data, the system taught in the ‘0086 application will provide personalized workout plans that produce the best results based on a user's genetic profile, even more tailored than a professional fitness trainer can provide. 

Whether using genetic data to create personalized recommendations is just a fad, or a technology that is here to stay is still to be determined. That being said, there are likely many more applications for this technology that have yet to be claimed. Make sure to check back to the AI Biotech/Diagnostics Patent Forecast® regularly to see what other uses for human genetic data emerge in the quickly growing field of gene-based recommendations.

 


Relevant Patent Documents

Application US20210050086  


Read more like this in News This Week!   or   Share this link with your connections!



301